Cargando…

Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma

BACKGROUND: Ameloblastoma is the most frequently encountered benign, locally invasive tumor. Attempts to surgically resect the tumor often leave small islands of tumor, which later result in recurrence in 50%–90% of cases. This has raised questions regarding the tumor cell populations that are respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanje, Manjushri Madhukar, Tanveer, Shahela, Ahmed, Syed Afroz, Kumar, Shravan, Vanje, Tejashree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948039/
https://www.ncbi.nlm.nih.gov/pubmed/31942121
http://dx.doi.org/10.4103/jomfp.JOMFP_152_17
_version_ 1783485677424345088
author Vanje, Manjushri Madhukar
Tanveer, Shahela
Ahmed, Syed Afroz
Kumar, Shravan
Vanje, Tejashree
author_facet Vanje, Manjushri Madhukar
Tanveer, Shahela
Ahmed, Syed Afroz
Kumar, Shravan
Vanje, Tejashree
author_sort Vanje, Manjushri Madhukar
collection PubMed
description BACKGROUND: Ameloblastoma is the most frequently encountered benign, locally invasive tumor. Attempts to surgically resect the tumor often leave small islands of tumor, which later result in recurrence in 50%–90% of cases. This has raised questions regarding the tumor cell populations that are responsible for tumor growth and recurrence. In ameloblastoma, whether or not cancer stem-like cells are present remains undetermined. However, if cancer stem-like cells are present in ameloblastoma, it is important to identify which type of cell possesses the stem-like characteristics and is responsible for ameloblastoma progression and recurrence. AIM: Our study aims at analyzing immunohistochemical staining to detect the expression of cancer stem cell (CSC) marker CD44 in relation to proliferative activity of tumor cells in histopathologically diagnosed cases of ameloblastoma variants and to derive a correlation between the CD44 expression and biologic behavior of the lesion. MATERIALS AND METHODS: A retrospective study, was conducted on total 25 cases ameloblastoma and were immunostained for CD44 expression. Results obtained were statistically analyzed. RESULTS: A positive correlation was observed between staining intensity of CD44 marker and the known biological behavior of the lesion. Intense staining reaction was found to be only in 8% cases, whereas 76% cases demonstrated moderate intensity and remaining 16% displayed mild immunoreactivity to CD44 marker. Staining location was more to be in stellate reticulum-like (SR-like) cells when compared to ameloblast-like (AB-like) cells. Intense immunostaining was localized in the small tumor follicles, especially in SR-like cells situated in close vicinity of peripheral AB-like cells whereas mild intensity of staining was observed in keratinizing areas. CONCLUSION: CSCs marker positive expression in benign tumor like ameloblastoma may be responsible for its aggressiveness and recurrence. CD44 marker may be of great value in predicting the biological behavior and growth potential of ameloblastoma.
format Online
Article
Text
id pubmed-6948039
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-69480392020-01-15 Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma Vanje, Manjushri Madhukar Tanveer, Shahela Ahmed, Syed Afroz Kumar, Shravan Vanje, Tejashree J Oral Maxillofac Pathol Original Article BACKGROUND: Ameloblastoma is the most frequently encountered benign, locally invasive tumor. Attempts to surgically resect the tumor often leave small islands of tumor, which later result in recurrence in 50%–90% of cases. This has raised questions regarding the tumor cell populations that are responsible for tumor growth and recurrence. In ameloblastoma, whether or not cancer stem-like cells are present remains undetermined. However, if cancer stem-like cells are present in ameloblastoma, it is important to identify which type of cell possesses the stem-like characteristics and is responsible for ameloblastoma progression and recurrence. AIM: Our study aims at analyzing immunohistochemical staining to detect the expression of cancer stem cell (CSC) marker CD44 in relation to proliferative activity of tumor cells in histopathologically diagnosed cases of ameloblastoma variants and to derive a correlation between the CD44 expression and biologic behavior of the lesion. MATERIALS AND METHODS: A retrospective study, was conducted on total 25 cases ameloblastoma and were immunostained for CD44 expression. Results obtained were statistically analyzed. RESULTS: A positive correlation was observed between staining intensity of CD44 marker and the known biological behavior of the lesion. Intense staining reaction was found to be only in 8% cases, whereas 76% cases demonstrated moderate intensity and remaining 16% displayed mild immunoreactivity to CD44 marker. Staining location was more to be in stellate reticulum-like (SR-like) cells when compared to ameloblast-like (AB-like) cells. Intense immunostaining was localized in the small tumor follicles, especially in SR-like cells situated in close vicinity of peripheral AB-like cells whereas mild intensity of staining was observed in keratinizing areas. CONCLUSION: CSCs marker positive expression in benign tumor like ameloblastoma may be responsible for its aggressiveness and recurrence. CD44 marker may be of great value in predicting the biological behavior and growth potential of ameloblastoma. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6948039/ /pubmed/31942121 http://dx.doi.org/10.4103/jomfp.JOMFP_152_17 Text en Copyright: © 2019 Journal of Oral and Maxillofacial Pathology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Vanje, Manjushri Madhukar
Tanveer, Shahela
Ahmed, Syed Afroz
Kumar, Shravan
Vanje, Tejashree
Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
title Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
title_full Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
title_fullStr Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
title_full_unstemmed Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
title_short Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
title_sort immunoexperssion of cancer stem cell marker (cd44) in ameloblastoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948039/
https://www.ncbi.nlm.nih.gov/pubmed/31942121
http://dx.doi.org/10.4103/jomfp.JOMFP_152_17
work_keys_str_mv AT vanjemanjushrimadhukar immunoexperssionofcancerstemcellmarkercd44inameloblastoma
AT tanveershahela immunoexperssionofcancerstemcellmarkercd44inameloblastoma
AT ahmedsyedafroz immunoexperssionofcancerstemcellmarkercd44inameloblastoma
AT kumarshravan immunoexperssionofcancerstemcellmarkercd44inameloblastoma
AT vanjetejashree immunoexperssionofcancerstemcellmarkercd44inameloblastoma